TMO Stock Recent News

Quantum-Si has a ton of promise if the proteomics market continues to develop. Thermo Fisher indicated the future potential with its big pending acquisition of Olink.

Thermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries.

Thermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS.

Thermo Fisher Scientific (TMO) reachead $519.43 at the closing of the latest trading day, reflecting a -1.65% change compared to its last close.

Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics.

Thermo Fisher Scientific (TMO) reachead $521.52 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.

Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.

Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.

Thermo Fisher Scientific is facing temporary revenue headwinds due to reduced COVID-19-related sales and cautious customer spending. The company's organic revenues are expected to bottom in FY24 and see a reacceleration in growth from FY25 onwards which can help the stock re-rate. TMO's valuation is cheap compared to historical averages and peers, offering a good buying opportunity.

Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.